Establishment of HRM method for quantitative determination for methylation level of DLC-1 promoter in prostate cancer and its clinical significance
10.3760/cma.j.issn.1009-9158.2010.03.003
- VernacularTitle:前列腺癌组织中DLC-1启动子甲基化定量检测的HRM方法建立及其应用意义
- Author:
Lin GUO
;
Xinju ZHANG
;
Ming GUAN
;
Ruilai LIU
;
Xiaoye GU
;
Weizhe MA
- Publication Type:Journal Article
- Keywords:
Prostatic neoplasms;
Tumor suppressor proteins;
Promoter regions(genetics);
Methylation
- From:
Chinese Journal of Laboratory Medicine
2010;33(3):205-208
- CountryChina
- Language:Chinese
-
Abstract:
Objective To establish quantitative method for detection of methylation level of DLC-1 promoter with HRM technology to analyze its association with pathological parameters in prostate cancer.Methods 89 prostate cancer tissue samples and 10 matched normal tissue samples were enrolled into this study.Prostate cancer cells were obtained by LCM.DNA was extracted and modified for methylation determination.CpGenome Universal Methylated DNA was chosen as 100% methylation sample.Then the calibrators representative of 100%,80%,50%,30%,10% and 0% methylation levels were prepared with dilution in a DNA sample of peripheral blood from healthy subjects(100% non-methylation).The DLC-1 methylation levels in prostate cancer tissue samples were detected with HRM.The associations of methylated level with age of patients,PSA value,TNM stage were investigated respectively.ResultsThe melting curves representing 100%,80%,50%,30%,10% and 0% methylation levels were aligned from right to left.The methylation levels of 10 adjacent normal samples and 35 prostate cancer samples were overlapped with 0% methylated calibrator.The methylation levels of 5 cancer samples ranged between 0% and 30%.The methylation levels of 29 cancer samples ranged between 31% and 80%.The methylation levels of 20 cancer samples ranged between 81% and 100%.HRM could be used to reliably detect the as low as 10% methylation for each assay,whereas methylation specific PCR(MSP) could be used to detect 30% methylation level.No significant association between methylation level and patients' age(X~2=3.29,P=0.19),PSA level(X~2=2.04,P=0.36) was found.However,DLC-1 methylation was higher in the prostate cancer tissues with advanced TNM stage(X~2=9.04,P=.01).Conclusions The quantitative method for DLC-1 methylation with HRM is successfully established.It is convenient with good reproducibility and high sensitivity.DLC-1 methylation could be used as the molecular marker for estimation of malignancy in prostate cancer.
